NASDAQ Companies

Preliminary 2023 Total Revenue of $430 million to $435 million, Crysvita® Revenue of $325 million to $330 million and Dojolvi® revenue […]

— Tim Kelly to lead Caribou’s technical operations strategy and execution — — CB-010 ANTLER Phase 1 trial initial dose […]

ALISO VIEJO, Calif., Jan. 07, 2024 (GLOBE NEWSWIRE) — RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality […]

MaxFuse enables matching and integration of datasets from spatial proteomics, spatial transcriptomics, single-cell sequencing, or other modalities Development and application […]

MARLBOROUGH, Mass., Jan. 07, 2024 (GLOBE NEWSWIRE) — Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced […]

LAS VEGAS, Jan. 07, 2024 (GLOBE NEWSWIRE) — Gentex Corporation (NASDAQ: GNTX) announced today the asset acquisition of eSight, a […]

MARLBOROUGH, Mass., Jan. 07, 2024 (GLOBE NEWSWIRE) — Akoya Biosciences, Inc., (NASDAQ: AKYA), The Spatial Biology Company®, today announced that […]

FORT MYERS, Fla., Jan. 05, 2024 (GLOBE NEWSWIRE) — Alico, Inc. (“Alico” or the “Company”) (NASDAQ: ALCO) announced today that […]

BEIJING, Jan. 05, 2024 (GLOBE NEWSWIRE) — Niu Technologies (“NIU”, or “the Company”) (NASDAQ: NIU), the world’s leading provider of […]

LAKE FOREST, Ill., Jan. 05, 2024 (GLOBE NEWSWIRE) — Assertio Holdings, Inc. (“Assertio” or the “Company”) (NASDAQ: ASRT), a specialty […]